G1 Therapeutics to Present Data on Trilaciclib at North America Conference on Lung Cancer (NACLC)

NEXT STORY
OncXerna Therapeutics to Participate at the Jefferies Virtual London Healthcare Conference
PREV STORY
Reata Pharmaceuticals, Inc. Announces Presentation of KIDNEYCODE Program at the American Society of Nephrology Kidney Week 2020 Reimagined
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chi-Med Announces NDA Acceptance in China for Surufatinib in Non-Pancreatic Neuroendocrine Tumors

author_avatar
NASDAQ Market News

Revolution Medicines Announces Proposed Public Offering of Common Stock

author_avatar
NASDAQ Market News

The Middle East & Africa RNAi therapeutics market is expected to reach US$ 29.02 million by 2027 from US$ 16.76 million in 2019

author_avatar
NASDAQ Market News